Hematology/Oncology

Top Story

NIH primary supporter of systematic reviews behind USPSTF recommendations

NIH primary supporter of systematic reviews behind USPSTF recommendations
May 24, 2018

Opioid prescriptions decline nearly 30% but remain ‘mainstay treatment’ for cancer-related pain

HemOnc Today, May 25, 2018
Prescription opioid volumes in the United States declined by 29% from their peak in 2011, according to a report on medicine use in the United States. Prescription opioid…
Advanced Practice

A team empowers a patient, and an empowered patient inspires the team

HemOnc Today, May 25, 2018
S. Scott Balderson, PA-C
Editor’s note:HemOnc Today’s regular columns for advanced practice providers (APPs) tackle common issues APPs face, discuss day-to-day practice and
Feature

Immunotherapy provides ‘paradigm shift’ for treatment of head and neck cancer

HemOnc Today, May 25, 2018
Immunotherapy agents have had a dramatic impact on a variety of cancer types. Research shows this impact extends to some patients with metastatic head and neck cancer…
Editorial

Cure and the shopping CAR T: Just pay millions at the cash register!

HemOnc Today, May 25, 2018
Derek Raghavan, MD, PhD
One of the truths about life in the United States is that lobbyists lobby. I imagine the reason that government has shown so little interest in the conundrum of paying…
More Headlines »
CME

Targeted Therapies for Metastatic HCC: Multidisciplinary Perspectives on the Latest Clinical Advances

This activity is supported by an educational grant from Bayer Healthcare Pharmaceuticals, Inc.

The incidence of hepatocellular carcinoma (HCC) continues to increase in the United States. Management of patients…
More »
Video
Meeting News

VIDEO: Tips for improving MIPS score, avoiding penalties

April 21, 2018
More »
Resource Centers
Immuno-Oncology Resource Center

Immuno-Oncology Resource Center

CME ABIM MOC

Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing over the past 3 Months

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the diagnosis and management of a 35-year-old man who…
More »
Current Issues
View the Current Issue
HemOnc Today